Home

Marvin L White

CIK 1493324 · Executive Chair · last filed 2026-08-10

Marvin L White is an Executive Chair who has filed 58 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing, for APVO, was dated Aug 10, 2026. Across all open-market trades the lifetime net is −$587.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $712.3K across reported positions. 21 SEC filings were submitted jointly with Emergent BioSolutions Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$712.3K

Companies

4

Total Filings

58

Lifetime Open-Market Net

-$587.6K

Filer Profile

Reported Address
2401 4TH AVE
SUITE 1050
SEATTLE, WA 99173
Related Filers
Emergent BioSolutions Inc. — 21 joint filings, latest 2026-05-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
APVO Executive Chair 1,667 $1.82 $3.0K $685.9K 30 2026-08-10
EBS Director 113,839 $6.23 $709.2K -$1.34M 17 2026-05-04
CoLucid Pharmaceuticals, Inc. (CLCD) Delisted Director — — — $0 6 2017-03-01
WASHINGTON PRIME GROUP INC. (WPG) Delisted Director 556 $0.83 $463 $71.2K 4 2016-05-19

Recent Filings

58 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-10 APVO Mixed +1,261 -$1.7K EDGAR
2026-05-04 EBS Grant (A) +25,344 $0 EDGAR
2025-08-08 APVO Grant (A) — $0 EDGAR
2025-07-21 APVO Exer (M) +10 $0 EDGAR
2025-05-02 EBS Grant (A) +34,403 $0 EDGAR
2025-03-04 APVO Exer (M) +14 $0 EDGAR
2024-11-13 EBS Sell (S) −14,287 -$171.0K EDGAR
2024-11-12 EBS Notice (144) −14,287 -$168.2K EDGAR
2024-07-19 APVO Grant (A) — $0 EDGAR
2024-05-28 EBS Grant (A) +17,430 $0 EDGAR
Showing 1–10 of 58
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.